APA (7th ed.) Citation

Janelidze, S., Stomrud, E., Smith, R., Palmqvist, S., Mattsson, N., Airey, D. C., . . . Hansson, O. (2020). Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer’s disease. Nature communications, 11(1), 1683-12. https://doi.org/10.1038/s41467-020-15436-0

Chicago Style (17th ed.) Citation

Janelidze, Shorena, et al. "Cerebrospinal Fluid P-tau217 Performs Better than P-tau181 as a Biomarker of Alzheimer’s Disease." Nature Communications 11, no. 1 (2020): 1683-12. https://doi.org/10.1038/s41467-020-15436-0.

MLA (9th ed.) Citation

Janelidze, Shorena, et al. "Cerebrospinal Fluid P-tau217 Performs Better than P-tau181 as a Biomarker of Alzheimer’s Disease." Nature Communications, vol. 11, no. 1, 2020, pp. 1683-12, https://doi.org/10.1038/s41467-020-15436-0.